SEC Company Response from PULSE BIOSCIENCES, INC. (PLSE) (CIK 0001625101) (PLSE) — May 10, 2016
PULSE BIOSCIENCES, INC. (PLSE) (CIK 0001625101)
Date: May 10, 2016 · CIK: 0001625101 · Accession: 0001193125-16-585807
AI Filing Summary & Sentiment
File numbers found in text: 333-208694
Show Raw Text
CORRESP 1 filename1.htm CORRESP MDB Capital Group LLC 2425 Cedar Springs Road Dallas, Texas 75201 May 10, 2016 Via EDGAR transmission U.S. Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Re: Pulse Biosciences, Inc. Registration Statement on Form S-1 Registration No. 333-208694 Ladies and Gentlemen: In connection with the above-captioned Registration Statement, we, the representative of the several underwriters, wish to advise you that 1,241 copies of the Preliminary Prospectus dated March 28, 2016 were distributed as follows: • 308 copies to institutions; and • 933 copies to individuals. The undersigned, as representative of the several underwriters, has and will, and each underwriter and dealer has advised the undersigned that it has and will, comply with the requirements of Rule 15c2-8 under the Securities Exchange Act of 1934, as amended. The several underwriters have adequate capital to underwrite a “firm commitment.” Very truly yours, MDB CAPITAL GROUP LLC By: /s/ Gary Schuman Name: Gary Schuman Title: CFO & CCO